Compare Aehr Test Systems (AEHR) vs Lemonade Inc (LMND) Price & Performance

AEHR trades at $72.33, up 3.38% today, with a bullish technical signal driven by oversold RSI readings near 24.5, though moving averages remain bearish. The company reported Q1 2026 EPS of -$0.05, beating expectations, but maintains negative profitability margins and cash flow. Recent news highlights strong order growth from AI and silicon photonics customers, including a follow-on system order announced June 17, 2026.

Outlook is mixed: robust order book and AI sector tailwinds support growth, but high P/S of 46.6 and persistent losses pose valuation risks. Analyst consensus is cautious with 33% buy ratings. Key risks include execution on orders and cash burn.

Lemonade (LMND) trades at $77.59, up 8.49% in the last session, showing strong momentum with a bullish technical outlook. The stock has consistently beaten earnings expectations in recent quarters, with revenue growth accelerating from $257M in 2022 to $738M in 2025. However, the company remains unprofitable with a -16.44% net income margin, though losses are narrowing. Recent expansion into new states and reinsurance program improvements provide positive catalysts.

While LMND shows promising growth and technical strength, the stock trades above the $71.75 analyst consensus target. The path to profitability remains the key challenge, with negative cash flow from operations and high valuation multiples creating risk. Investors face a trade-off between strong revenue growth and persistent losses in a competitive insurance market.